Overexpression of Sigma1 Receptor and Its Positive Associations With Pathologic TNM Classification in Esophageal Squamous Cell Carcinoma

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 6, 2012, Pages 457-466

  Xu, Qing Xia ^a   Li, En Min ^a   Zhang, Yong Fa ^a   Liao, Lian Di ^a   Xu, Xiu E ^a   Wu, Zhi Yong ^a   Shen, Jin Hui ^a   Xu, Li Yan ^a  

^a SHANTOU CENTRAL HOSPITAL   (China)

Author keywords

esophageal squamous cell carcinoma; pathologic TNM classification; sigma1 receptor

Indexed keywords

SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR;

ADULT; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CELL NUCLEUS; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; CELL TRANSFORMATION; EPITHELIUM; ESOPHAGUS TUMOR; KAPLAN MEIER METHOD; LYMPH NODE; METABOLISM; METASTASIS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; ESOPHAGEAL NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; RECEPTORS, SIGMA;

EID: 84864101935     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412443542     Document Type: Article

References (35)

1. Aydar E,Onganer P,Perrett R,Djamgoz MB,Palmer CP.The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines.Cancer Lett. 2006;242:245-257.
2. Aydar E,Palmer CP,Klyachko VA,Jackson MB.The sigma receptor as a ligand-regulated auxiliary potassium channel subunit.Neuron. 2002;34:399-410.
3. Bem WT,Thomas GE,Mamone JY,Homan SM,Levy BK,Johnson FE,Coscia CJ.Overexpression of sigma receptors in nonneural human tumors.Cancer Res. 1991;51:6558-6562.
4. Brent PJ,Pang GT.Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture.Eur J Pharmacol. 1995;278:151-160.
5. Christein JD,Hollinger EF,Millikan KW.Prognostic factors associated with resectable carcinoma of the esophagus.Am Surg. 2002;68:258-262.
6. Establishment of an epithelial cell line from human esophageal carcinoma.Chin Med J. 1976;2:357-364.
7. Crawford KW,Bowen WD.Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.Cancer Res. 2002;62:313-322.
8. Dussossoy D,Carayon P,Belugou S,Feraut D,Bord A,Goubet C,Roque C,Vidal H,Combes T,Loison G, et al.Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level.Eur J Biochem. 1999;263:377-386.
9. Fraser SP,Grimes JA,Djamgoz MB.Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines.Prostate. 2000;44:61-76.
10. Georgatos SD,Meier J,Simos G.Lamins and lamin-associated proteins.Curr Opin Cell Biol. 1994;6:347-353.
11. Guitart X,Codony X,Monroy X.Sigma receptors: biology and therapeutic potential.Psychopharmacology. 2004;174:301-319.
12. Hanner M,Moebius FF,Flandorfer A,Knaus HG,Striessnig J,Kempner E,Glossmann H.Purification, molecular cloning, and expression of the mammalian sigma1-binding site.Proc Natl Acad Sci U S A. 1996;93:8072-8077.
13. Hayashi T,Su TP.Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export.J Pharmacol Exp Ther. 2003;306:718-725.
14. Hellewell SB,Bruce A,Feinstein G,Orringer J,Williams W,Bowen WD.Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.Eur J Pharmacol. 1994;268:9-18.
15. Ishiguro H,Ohtsuki T,Toru M,Itokawa M,Aoki J,Shibuya H,Kurumaji A,Okubo Y,Iwawaki A,Ota K, et al.Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia.Neurosci Lett. 1998;257:45-48.
16. John CS,Bowen WD,Varma VM,McAfee JG,Moody TW.Sigma receptors are expressed in human non-small cell lung carcinoma.Life Sci. 1995;56:2385-2392.
17. Kekuda R,Prasad PD,Fei YJ,Leibach FH,Ganapathy V.Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).Biochem Biophys Res Commun. 1996;229:553-558.
18. Martin WR,Eades CG,Thompson JA,Huppler RE,Gilbert PE.The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog.J Pharmacol Exp Ther. 1976;197:517-532.
19. Moody TW,Leyton J,John C.Sigma ligands inhibit the growth of small cell lung cancer cells.Life Sci. 2000;66:1979-1986.
20. Ouadid-Ahidouch H,Chaussade F,Roudbaraki M,Slomianny C,Dewailly E,Delcourt P,Prevarskaya N.KV1.1 K+ channels identification in human breast carcinoma cells: involvement in cell proliferation.Biochem Biophys Res Commun. 2000;278:272-277.
21. Parkin DM,Bray F,Ferlay J,Pisani P.Global cancer statistics, 2002.CA Cancer J Clin. 2005;55:74-108.
22. Quirion R,Bowen WD,Itzhak Y,Junien JL,Musacchio JM,Rothman RB,Su TP,Tam SW,Taylor DP.A proposal for the classification of sigma binding sites.Trends Pharmacol Sci. 1992;13:85-86.
23. Reed CE.Surgical management of esophageal carcinoma.Oncologist. 1999;4:95-105.
24. Ruscher K,Shamloo M,Rickhag M,Ladunga I,Soriano L,Gisselsson L,Toresson H,Ruslim-Litrus L,Oksenberg D,Urfer R, et al.The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.Brain. 2011;134:732-746.
25. Shimada H,Nabeya Y,Okazumi S,Matsubara H,Shiratori T,Gunji Y,Kobayashi S,Hayashi H,Ochiai T.Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.Surgery. 2003;133:486-494.
26. Shimada Y,Imamura M,Wagata T,Yamaguchi N,Tobe T.Characterization of twenty-one newly established esophageal cancer cell lines.Cancer. 1992;69:277-284.
27. Spruce BA,Campbell LA,McTavish N,Cooper MA,Appleyard MV,O'Neill M,Howie J,Samson J,Watt S,Murray K, et al.Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.Cancer Res. 2004;64:4875-4886.
28. Stoner GD,Gupta A.Etiology and chemoprevention of esophageal squamous cell carcinoma.Carcinogenesis. 2001;22:1737-1746.
29. Su TP.Delineating biochemical and functional properties of sigma receptors: emerging concepts.Crit Rev Neurobiol. 1993;7:187-203.
30. Thomas GE,Szucs M,Mamone JY,Bem WT,Rush MD,Johnson FE,Coscia CJ.Sigma and opioid receptors in human brain tumors.Life Sci. 1990;46:1279-1286.
31. Vilner BJ,John CS,Bowen WD.Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.Cancer Res. 1995;55:408-413.
32. Wolfe SA,Culp SG,De Souza EB.Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary.Endocrinology. 1989;124:1160-1172.
33. Yang L,Guan T,Gerace L.Integral membrane proteins of the nuclear envelope are dispersed throughout the endoplasmic reticulum during mitosis.J Cell Biol. 1997;137:1199-1210.
34. Yao X,Kwan HY.Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer.Life Sci. 1999;65:55-62.
35. Zhang FR,Tao LH,Shen ZY,Lv Z,Xu LY,Li EM.Fascin expression in human embryonic, fetal, and normal adult tissue.J Histochem Cytochem. 2008;56:193-199.